Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1996 Apr 1;97(7):1597–1604. doi: 10.1172/JCI118584

Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice.

S Takahashi 1, L Fossati 1, M Iwamoto 1, R Merino 1, R Motta 1, T Kobayakawa 1, S Izui 1
PMCID: PMC507222  PMID: 8601623

Abstract

To investigate the respective roles of Th1 and Th2 cells in the pathogenesis of lupus-like autoimmune disease, we have analyzed the spontaneous and antigen-induced productions of IgG1 vs IgG2a and IgG3 subclasses in relation to the mRNA expression of INF-gamma (Th1 cytokine promoting IgG2a and IgG3 production), IL-4 (Th2 cytokine promoting IgG1 production), and IL-10 (Th2 cytokine) in CD4+ T cells from lupus-prone MRL mice. For this purpose, two paired sets of MRL mice were chosen for the comparison of these parameters: (a) MRL-lpr/lpr (lpr for lymphoproliferation) and its recently described substrain with a prolonged survival, termed MRL-lpr/lpr.ll (ll for long lived) and (b) MRL male mice bearing the Yaa (Y-linked autoimmune acceleration) gene (MRL.Yaa) with an accelerated disease and their male counterparts lacking the Yaa gene. We demonstrate herein that the accelerated development of lupus-like autoimmune disease in MRL-lpr/lpr and MRL.Yaa mice, as compared with MRL-lpr/lpr.ll and MRL-+/+ mice, respectively, was correlated with an enhanced expression of IFN-gamma vs IL-4 and IL-10 mRNA in CD4+ T cells, which paralleled with an increase of spontaneous and foreign T cell-dependent antigen-induced productions of IgG2a and IgG3 vs IgG1 antibodies. These data suggest that an imbalance towards Th1 predominance may play a significant role in the acceleration of lupus-like autoimmune disease in MRL mice.

Full Text

The Full Text of this article is available as a PDF (341.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abramowicz D., Doutrelepont J. M., Lambert P., Van der Vorst P., Bruyns C., Goldman M. Increased expression of Ia antigens on B cells after neonatal induction of lymphoid chimerism in mice: role of interleukin 4. Eur J Immunol. 1990 Mar;20(3):469–476. doi: 10.1002/eji.1830200303. [DOI] [PubMed] [Google Scholar]
  2. Andrews B. S., Eisenberg R. A., Theofilopoulos A. N., Izui S., Wilson C. B., McConahey P. J., Murphy E. D., Roths J. B., Dixon F. J. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med. 1978 Nov 1;148(5):1198–1215. doi: 10.1084/jem.148.5.1198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bazin H., Cormont F., De Clercq L. Purification of rat monoclonal antibodies. Methods Enzymol. 1986;121:638–652. doi: 10.1016/0076-6879(86)21063-0. [DOI] [PubMed] [Google Scholar]
  4. Berney T., Fulpius T., Shibata T., Reininger L., Van Snick J., Shan H., Weigert M., Marshak-Rothstein A., Izui S. Selective pathogenicity of murine rheumatoid factors of the cryoprecipitable IgG3 subclass. Int Immunol. 1992 Jan;4(1):93–99. doi: 10.1093/intimm/4.1.93. [DOI] [PubMed] [Google Scholar]
  5. Chirgwin J. M., Przybyla A. E., MacDonald R. J., Rutter W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 1979 Nov 27;18(24):5294–5299. doi: 10.1021/bi00591a005. [DOI] [PubMed] [Google Scholar]
  6. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  7. Dobashi K., Ono S., Murakami S., Takahama Y., Katoh Y., Hamaoka T. Polyclonal B cell activation by a B cell differentiation factor, B151-TRF2. III. B151-TRF2 as a B cell differentiation factor closely associated with autoimmune disease. J Immunol. 1987 Feb 1;138(3):780–787. [PubMed] [Google Scholar]
  8. Doutrelepont J. M., Moser M., Leo O., Abramowicz D., Vanderhaegen M. L., Urbain J., Goldman M. Hyper IgE in stimulatory graft-versus-host disease: role of interleukin-4. Clin Exp Immunol. 1991 Jan;83(1):133–136. doi: 10.1111/j.1365-2249.1991.tb05602.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Erausquin C., Merino R., Izui S., Fernandez-Sueiro L., Saez F., Fernandez F., Rodriguez-Valverde V., Merino J. Therapeutic effect of early thymic irradiation in (NZB x NZW)F1 mice, associated with a selective decrease in the levels of IgG3 and gp70-anti-gp70 immune complexes. Cell Immunol. 1995 Apr 1;161(2):207–212. doi: 10.1006/cimm.1995.1028. [DOI] [PubMed] [Google Scholar]
  10. Fossati L., Iwamoto M., Merino R., Izui S. Selective enhancing effect of the Yaa gene on immune responses against self and foreign antigens. Eur J Immunol. 1995 Jan;25(1):166–173. doi: 10.1002/eji.1830250128. [DOI] [PubMed] [Google Scholar]
  11. Fossati L., Takahashi S., Merino R., Iwamoto M., Aubry J. P., Nose M., Spach C., Motta R., Izui S. An MRL/MpJ-lpr/lpr substrain with a limited expansion of lpr double-negative T cells and a reduced autoimmune syndrome. Int Immunol. 1993 May;5(5):525–532. doi: 10.1093/intimm/5.5.525. [DOI] [PubMed] [Google Scholar]
  12. Fulpius T., Spertini F., Reininger L., Izui S. Immunoglobulin heavy chain constant region determines the pathogenicity and the antigen-binding activity of rheumatoid factor. Proc Natl Acad Sci U S A. 1993 Mar 15;90(6):2345–2349. doi: 10.1073/pnas.90.6.2345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Goldman M., Druet P., Gleichmann E. TH2 cells in systemic autoimmunity: insights from allogeneic diseases and chemically-induced autoimmunity. Immunol Today. 1991 Jul;12(7):223–227. doi: 10.1016/0167-5699(91)90034-Q. [DOI] [PubMed] [Google Scholar]
  14. Hudgins C. C., Steinberg R. T., Klinman D. M., Reeves M. J., Steinberg A. D. Studies of consomic mice bearing the Y chromosome of the BXSB mouse. J Immunol. 1985 Jun;134(6):3849–3854. [PubMed] [Google Scholar]
  15. Ishida H., Muchamuel T., Sakaguchi S., Andrade S., Menon S., Howard M. Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J Exp Med. 1994 Jan 1;179(1):305–310. doi: 10.1084/jem.179.1.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Izui S., Higaki M., Morrow D., Merino R. The Y chromosome from autoimmune BXSB/MpJ mice induces a lupus-like syndrome in (NZW x C57BL/6)F1 male mice, but not in C57BL/6 male mice. Eur J Immunol. 1988 Jun;18(6):911–915. doi: 10.1002/eji.1830180612. [DOI] [PubMed] [Google Scholar]
  17. Izui S., Kelley V. E., Masuda K., Yoshida H., Roths J. B., Murphy E. D. Induction of various autoantibodies by mutant gene lpr in several strains of mice. J Immunol. 1984 Jul;133(1):227–233. [PubMed] [Google Scholar]
  18. Izui S., Masuda K., Yoshida H. Acute SLE in F1 hybrids between SB/Le and NZW mice; prominently enhanced formation of gp70 immune complexes by a Y chromosome-associated factor from SB/Le mice. J Immunol. 1984 Feb;132(2):701–704. [PubMed] [Google Scholar]
  19. Jacob C. O., van der Meide P. H., McDevitt H. O. In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon. J Exp Med. 1987 Sep 1;166(3):798–803. doi: 10.1084/jem.166.3.798. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Jevnikar A. M., Grusby M. J., Glimcher L. H. Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice. J Exp Med. 1994 Apr 1;179(4):1137–1143. doi: 10.1084/jem.179.4.1137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Labit C., Pierres M. Rat monoclonal antibodies to mouse IgG1, IgG2a, IgG2b, and IgG3 subclasses, and kappa chain isotypic determinants. Hybridoma. 1984 Summer;3(2):163–169. doi: 10.1089/hyb.1984.3.163. [DOI] [PubMed] [Google Scholar]
  22. Lemoine R., Berney T., Shibata T., Fulpius T., Gyotoku Y., Shimada H., Sawada S., Izui S. Induction of "wire-loop" lesions by murine monoclonal IgG3 cryoglobulins. Kidney Int. 1992 Jan;41(1):65–72. doi: 10.1038/ki.1992.9. [DOI] [PubMed] [Google Scholar]
  23. Llorente L., Zou W., Levy Y., Richaud-Patin Y., Wijdenes J., Alcocer-Varela J., Morel-Fourrier B., Brouet J. C., Alarcon-Segovia D., Galanaud P. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J Exp Med. 1995 Mar 1;181(3):839–844. doi: 10.1084/jem.181.3.839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Luzuy S., Merino J., Engers H., Izui S., Lambert P. H. Autoimmunity after induction of neonatal tolerance to alloantigens: role of B cell chimerism and F1 donor B cell activation. J Immunol. 1986 Jun 15;136(12):4420–4426. [PubMed] [Google Scholar]
  25. Merino R., Fossati L., Iwamoto M., Takahashi S., Lemoine R., Ibnou-Zekri N., Pugliatti L., Merino J., Izui S. Effect of long-term anti-CD4 or anti-CD8 treatment on the development of lpr CD4- CD8- double negative T cells and of the autoimmune syndrome in MRL-lpr/lpr mice. J Autoimmun. 1995 Feb;8(1):33–45. doi: 10.1006/jaut.1995.0003. [DOI] [PubMed] [Google Scholar]
  26. Merino R., Iwamoto M., Fossati L., Izui S. Polyclonal B cell activation arises from different mechanisms in lupus-prone (NZB x NZW)F1 and MRL/MpJ-lpr/lpr mice. J Immunol. 1993 Dec 1;151(11):6509–6516. [PubMed] [Google Scholar]
  27. Merino R., Shibata T., De Kossodo S., Izui S. Differential effect of the autoimmune Yaa and lpr genes on the acceleration of lupus-like syndrome in MRL/MpJ mice. Eur J Immunol. 1989 Nov;19(11):2131–2137. doi: 10.1002/eji.1830191124. [DOI] [PubMed] [Google Scholar]
  28. Noma Y., Sideras P., Naito T., Bergstedt-Lindquist S., Azuma C., Severinson E., Tanabe T., Kinashi T., Matsuda F., Yaoita Y. Cloning of cDNA encoding the murine IgG1 induction factor by a novel strategy using SP6 promoter. Nature. 1986 Feb 20;319(6055):640–646. doi: 10.1038/319640a0. [DOI] [PubMed] [Google Scholar]
  29. Oi V. T., Herzenberg L. A. Localization of murine Ig-1b and Ig-1a (IgG 2a) allotypic determinants detected with monoclonal antibodies. Mol Immunol. 1979 Dec;16(12):1005–1017. doi: 10.1016/0161-5890(79)90034-8. [DOI] [PubMed] [Google Scholar]
  30. Rousset F., Garcia E., Defrance T., Péronne C., Vezzio N., Hsu D. H., Kastelein R., Moore K. W., Banchereau J. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1890–1893. doi: 10.1073/pnas.89.5.1890. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Santoro T. J., Portanova J. P., Kotzin B. L. The contribution of L3T4+ T cells to lymphoproliferation and autoantibody production in MRL-lpr/lpr mice. J Exp Med. 1988 May 1;167(5):1713–1718. doi: 10.1084/jem.167.5.1713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Schurmans S., Heusser C. H., Qin H. Y., Merino J., Brighouse G., Lambert P. H. In vivo effects of anti-IL-4 monoclonal antibody on neonatal induction of tolerance and on an associated autoimmune syndrome. J Immunol. 1990 Oct 15;145(8):2465–2473. [PubMed] [Google Scholar]
  33. Snapper C. M., McIntyre T. M., Mandler R., Pecanha L. M., Finkelman F. D., Lees A., Mond J. J. Induction of IgG3 secretion by interferon gamma: a model for T cell-independent class switching in response to T cell-independent type 2 antigens. J Exp Med. 1992 May 1;175(5):1367–1371. doi: 10.1084/jem.175.5.1367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Snapper C. M., Mond J. J. Towards a comprehensive view of immunoglobulin class switching. Immunol Today. 1993 Jan;14(1):15–17. doi: 10.1016/0167-5699(93)90318-F. [DOI] [PubMed] [Google Scholar]
  35. Snapper C. M., Paul W. E. Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science. 1987 May 22;236(4804):944–947. doi: 10.1126/science.3107127. [DOI] [PubMed] [Google Scholar]
  36. Steinberg E. B., Santoro T. J., Chused T. M., Smathers P. A., Steinberg A. D. Studies of congenic MRL-Ipr/Ipr.xid mice. J Immunol. 1983 Dec;131(6):2789–2795. [PubMed] [Google Scholar]
  37. Strasser A., Whittingham S., Vaux D. L., Bath M. L., Adams J. M., Cory S., Harris A. W. Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8661–8665. doi: 10.1073/pnas.88.19.8661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Takahashi S., Itoh J., Nose M., Ono M., Yamamoto T., Kyogoku M. Cloning and cDNA sequence analysis of nephritogenic monoclonal antibodies derived from an MRL/lpr lupus mouse. Mol Immunol. 1993 Feb;30(2):177–182. doi: 10.1016/0161-5890(93)90089-t. [DOI] [PubMed] [Google Scholar]
  39. Takahashi S., Nose M., Sasaki J., Yamamoto T., Kyogoku M. IgG3 production in MRL/lpr mice is responsible for development of lupus nephritis. J Immunol. 1991 Jul 15;147(2):515–519. [PubMed] [Google Scholar]
  40. Trinchieri G. Interleukin-12 and its role in the generation of TH1 cells. Immunol Today. 1993 Jul;14(7):335–338. doi: 10.1016/0167-5699(93)90230-I. [DOI] [PubMed] [Google Scholar]
  41. Watanabe-Fukunaga R., Brannan C. I., Copeland N. G., Jenkins N. A., Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature. 1992 Mar 26;356(6367):314–317. doi: 10.1038/356314a0. [DOI] [PubMed] [Google Scholar]
  42. Wofsy D. Administration of monoclonal anti-T cell antibodies retards murine lupus in BXSB mice. J Immunol. 1986 Jun 15;136(12):4554–4560. [PubMed] [Google Scholar]
  43. Wofsy D., Hardy R. R., Seaman W. E. The proliferating cells in autoimmune MRL/lpr mice lack L3T4, an antigen on "helper" T cells that is involved in the response to class II major histocompatibility antigens. J Immunol. 1984 Jun;132(6):2686–2689. [PubMed] [Google Scholar]
  44. Wu J., Zhou T., Zhang J., He J., Gause W. C., Mountz J. D. Correction of accelerated autoimmune disease by early replacement of the mutated lpr gene with the normal Fas apoptosis gene in the T cells of transgenic MRL-lpr/lpr mice. Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2344–2348. doi: 10.1073/pnas.91.6.2344. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES